Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.54 |
| ▸ | FNTB | P49356 | 1/20 | 0.54 |
| ▸ | GABBR2 | O75899 | 4/20 | 0.52 |
| ▸ | GABBR1 | Q9UBS5 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.47 |
| ▸ | ITGAV | P06756 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657719 | 0.89 | FNTA (0.50) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL16249736 | 0.89 | GABBR2 (0.61) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL21773927 | 0.88 | FFAR1 (0.52) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL21773925 | 0.88 | FFAR1 (0.52) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL27511611 | 0.87 | GABBR2 (0.45) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL31339236 | 0.86 | FNTA (0.51) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL10523496 | 0.84 | MIF (0.54) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL31339242 | 0.83 | F2 (0.46) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL657081 | 0.82 | ATM (0.55) | FNTAFNTBGABBR2GABBR1KMT2A | |
| SCHEMBL6180314 | 0.81 | ESR1 (0.51) | FNTAFNTBGABBR2GABBR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841766-A | Preparation method and application of glutarimide compound | 上海凌凯科技股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| WO-2026097750-A1 | METHOD FOR SYNTHESIZING ARYL-SUBSTITUTED CHIRAL TETRAHYDROPYRAN RING BY MEANS OF DE-SYMMETRIZATION | 杭州澳赛诺生物科技有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-119841766-A | Preparation method and application of glutarimide compound | 上海凌凯科技股份有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4536357-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | The Broad Institute, Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| US-20250109165-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2025-04-03 | — | — | US | disclosed |
| CN-119101040-B | Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis | 杭州澳赛诺医药技术有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119101040-A | Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis | 杭州澳赛诺医药技术有限公司 | 2024-12-10 | — | — | CN | disclosed |
| WO-2024059808-A1 | WEE1 INHIBITORS AND METHODS FOR TREATING CANCER | RECURIUM IP HOLDINGS, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023239925-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023239925-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-6235750-B1 | NITRIC OXIDE SYNTHASE INHIBITOR | PFIZER INC | 2001-05-22 | — | — | US | disclosed |
| WO-2000071107-A2 | NEW PHARMACEUTICAL COMBINATIONS FOR NOS INHIBITORS | PFIZER PRODUCTS INC. (US) | 2000-11-30 | — | — | WO | disclosed |
| US-6043284-A | ACYL COENZYME A: CHOLESTEROL ACYLTRANSFERASE (ACAT) INHIBITORS | GLAXO WELLCOME INC. (US) | 2000-03-28 | — | — | US | disclosed |
| WO-2000009130-A2 | NEW PHARMACEUTICAL USES FOR NOS INHIBITORS | PFIZER PRODUCTS INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| CN-1239952-A | 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors | PFIZER (US) | 1999-12-29 | — | — | CN | disclosed |
| EP-0946512-A1 | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS | PFIZER INC. (US) | 1999-10-06 | — | — | EP | disclosed |
| US-5776951-A | ANTICHOLESTEROL AGENT | GLAXO WELLCOME INC. (US) | 1998-07-07 | — | — | US | disclosed |
| WO-1998024766-A1 | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS | PFIZER INC. (US) | 1998-06-11 | — | — | WO | disclosed |
| EP-0706508-A1 | ANTI-ATHEROSCLEROTIC DIARYL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1996-04-17 | — | — | EP | disclosed |
| WO-1995001326-A1 | ANTI-ATHEROSCLEROTIC DIARYL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109165-A1 | CYCLOPHILIN INHIBITORS AND USES THEREOF | PPIF, PPID, PPIG | FNTA 2903/4885FNTB 2820/4885GABBR2 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.